AK&M 01 July 2025 12:45
Torrent Pharmaceuticals Secures .3 Billion Credit Line for Strategic Acquisition
In a significant move within the pharmaceutical sector, Torrent Pharmaceuticals Ltd., a prominent Indian multinational, has successfully secured a credit line amounting to .3 billion. This financial maneuver is aimed at facilitating the acquisition of a controlling stake in JB Chemicals & Pharmaceuticals Ltd., as detailed in a recent press release from Torrent.
The credit facility is backed by a consortium of reputable banks, including Barclays Plc, HSBC Holdings Plc, and Standard Chartered Plc. The terms of the credit line include the issuance of bonds in local currency, with a maturity period extending up to four years.
As part of this strategic acquisition, Torrent plans to acquire 53.8% of JB Chemicals from the American investment firm KKR & Co. for approximately .4 billion. Additionally, Torrent has submitted a mandatory offer to purchase an extra 26% of JB Chemicals’ shares at a price of 1,639 rupees per share.
JB Chemicals has seen a remarkable increase in market valuation, reaching .6 billion in 2024, buoyed by a 20% rise in its stock price. This growth reflects the company’s robust performance in the pharmaceutical market.
The year 2025 has witnessed a notable uptick in cross-border deal-making within India’s M&A landscape, attributed to favorable regulatory policies and government initiatives, alongside the burgeoning Indian economy. While transaction volumes in the Asia-Pacific region have dipped by 8%, India has experienced an impressive 18% increase in M&A activity.
JB Chemicals specializes in the production of pharmaceutical products targeting cardiovascular, central nervous system, and gastrointestinal disorders. The company’s offerings include herbal medicines and active pharmaceutical ingredients, alongside services such as formulation optimization, scale-up production, and regulatory support. Its headquarters are located in Mumbai, India.
On the other hand, Torrent Pharmaceuticals stands as a key player in the international pharmaceutical arena, engaging in a wide array of healthcare programs and manufacturing a diverse range of medications. As one of the largest entities in India’s medical industry, Torrent is headquartered in Ahmedabad, India.
For more insights, follow our Telegram channel “Mergers and Acquisitions. AK&M.”
